Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy

Neurology

Volumn 84, Issue 13, 2015, Pages 1346-1354

  Stenzel, Werner ^a   Preuße, Corinna ^a   Allenbach, Yves ^b   Pehl, Debora ^a   Junckerstorff, Reimar ^c,d   Heppner, Frank L ^a   Nolte, Kay ^e   Aronica, Eleonora ^g   Kana, Veronika ^h   Rushing, Elisabeth ^h   Schneider, Udo ^a   Claeys, Kristl G ^e,f   Benveniste, Olivier ^b   Weis, Joachim ^e   Goebel, Hans H ^a,i  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e RWTH AACHEN UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF ZURICH   (Switzerland)

ⁱ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN;

ACTIN FILAMENT; ANTISYNTHETASE SYNDROME; ARTICLE; CELL AGGREGATION; CELL INCLUSION; CLINICAL ARTICLE; DYSIMMUNE MYOPATHY; ELECTRON MICROSCOPY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; MYOSITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; BIOPSY; CELL NUCLEUS INCLUSION BODY; COMPLICATION; METABOLISM; NECROSIS; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; ULTRASTRUCTURE;

ACTIN CYTOSKELETON; ACTINS; BIOPSY; HUMANS; INTRANUCLEAR INCLUSION BODIES; MUSCLE, SKELETAL; MYOSITIS; NECROSIS; SENSITIVITY AND SPECIFICITY;

EID: 84931052750     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001422     Document Type: Article

References (36)

1. Hervier B, Benveniste O. Clinical heterogeneity and outcomes of antisynthetase syndrome. Curr Rheumatol Rep 2013;15:349-358.
2. Fathi M, Vikgren J, Boijsen M, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008;59:677-685.
3. Francoeur AM, Mathews MB. Interaction between VA RNA and the lupus antigen La: formation of a ribonucleoprotein particle in vitro. Proc Natl Acad Sci USA 1982; 79:6772-6776.
4. Gunawardena H, Betteridge ZE, McHugh NJ. Myositisspecific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 2009;48: 607-612.
5. Park SG, Schimmel P, Kim S. Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci USA 2008;105:11043-11049.
6. Mathews MB, Reichlin M, Hughes GR, Bernstein RM. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 1984;160:420-434.
7. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983;304:177-179.
8. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003;32:273-284.
9. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases: a marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983;26:604-611.
10. Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011;63:3439-3447.
11. Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC International Workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October, 2003, Naarden, the Netherlands. Neuromuscul Disord 2004;14:337-345.
12. Brady S, Squier W, Hilton-Jones D. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 2013;84:1240-1246.
13. Preusse C, Goebel HH, Held J, et al. Immune-mediated necrotizing myopathy is characterized by a specific Th1-m1 polarized immune profile. Am J Pathol 2012; 181:2161-2171.
14. Gonsior SM, Platz S, Buchmeier S, Scheer U, Jockusch BM, Hinssen H. Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J Cell Sci 1999;112:797-809.
15. Schoenenberger CA, Buchmeier S, Boerries M, Sutterlin R, Aebi U, Jockusch BM. Conformation-specific antibodies reveal distinct actin structures in the nucleus and the cytoplasm. J Struct Biol 2005;152:157-168.
16. Domazetovska A, Ilkovski B, Cooper ST, et al. Mechanisms underlying intranuclear rod formation. Brain 2007; 130:3275-3284.
17. Domazetovska A, Ilkovski B, Kumar V, et al. Intranuclear rod myopathy: molecular pathogenesis and mechanisms of weakness. Ann Neurol 2007;62:597-608.
18. Huet G, Skarp KP, Vartiainen MK. Nuclear actin levels as an important transcriptional switch. Transcription 2012;3: 226-230.
19. Bettinger BT, Gilbert DM, Amberg DC. Actin up in the nucleus. Nat Rev Mol Cell Biol 2004;5:410-415.
20. Gieni RS, Hendzel MJ. Actin dynamics and functions in the interphase nucleus: moving toward an understanding of nuclear polymeric actin. Biochem Cell Biol 2009;87: 283-306.
21. Stuven T, Hartmann E, Gorlich D. Exportin 6: a novel nuclear export receptor that is specific for profilin actin complexes. EMBO J 2003;22:5928-5940.
22. Munsie LN, Truant R. The role of the cofilin-actin rod stress response in neurodegenerative diseases uncovers potential new drug targets. Bioarchitecture 2012;2: 204-208.
23. Fukui Y, Katsumaru H. Nuclear actin bundles in amoeba, dictyostelium and human HeLa cells induced by dimethyl sulfoxide. Exp Cell Res 1979;120:451-455.
24. Xu YZ, Thuraisingam T, Morais DA, Rola-Pleszczynski M, Radzioch D. Nuclear translocation of beta-actin is involved in transcriptional regulation during macrophage differentiation of HL-60 cells. Mol Biol Cell 2010;21: 811-820.
25. Nishida E, Iida K, Yonezawa N, Koyasu S, Yahara I, Sakai H. Cofilin is a component of intranuclear and cytoplasmic actin rods induced in cultured cells. Proc Natl Acad Sci USA 1987;84:5262-5266.
26. Schroder JM, Krabbe B, Weis J. Oculopharyngeal muscular dystrophy: clinical and morphological follow-up study reveals mitochondrial alterations and unique nuclear inclusions in a severe autosomal recessive type. Neuropathol Appl Neurobiol 1995;21:68-73.
27. Paulus W, Peiffer J, Becker I, Roggendorf W, Schumm F. Adult-onset rod disease with abundant intranuclear rods. J Neurol 1988;235:343-347.
28. Benveniste O, Laforet P, Dubourg O, et al. Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy. Neurology 2008;71:531-532.
29. Olive M, Odgerel Z, Martinez A, et al. Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord 2011;21:533-542.
30. Schroder R, Kunz WS, Rouan F, et al. Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy. J Neuropathol Exp Neurol 2002;61:520-530.
31. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with antiaminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 2013;8:e60442.
32. Brouwer R, Hengstman GJ, Vree Egberts W, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116-123.
33. Marie I, Hachulla E, Hatron PY, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 2001;28: 2230-2237.
34. Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry 2000;68:472-478.
35. Pestronk A. Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol 2004;23:595-604.
36. Miller FW, Waite KA, Biswas T, Plotz PH. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci USA 1990;87:9933-9937.